Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8316)
All Articles published online
|
Publishing Process of This Article
|
Dec 8, 2015 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Seifert LL, Perumpail RB, Ahmed A. Update on hepatitis C: Direct-acting antivirals. World J Hepatol 2015; 7(28): 2829-2833 [PMID: 26668694 DOI: 10.4254/wjh.v7.i28.2829] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i28/2829.htm |
| Number | Citing Articles |
| 1 |
Kathleen A. McGinnis, Matthew S. Suffoletto. The U. S. Department of Veterans Affairs (VA) as a model for stronger public health infrastructure to combat HCV and other infectious diseases and reduce disparities. EClinicalMedicine 2020; 22: 100391 doi: 10.1016/j.eclinm.2020.100391
|
| 2 |
Alyssa M. Austria, Vjera Ninčević, George Y. Wu. Update on Hepatitis C. 2017; doi: 10.5772/intechopen.70685
|
| 3 |
Mira Hleyhel, Julia Geller, Amal Sadou, Paul Naaber, Tatiana Kuznetsova, Sigrid Vorobjov, Marleen Lõhmus, Martina Furegato, Suzanne Reed, Benjamin Bluemel, Erika Duffell, Kristi Rüütel. Prevalence of chronic hepatitis C infection in the general population: results from a national survey, Estonia, July to December 2022.
Eurosurveillance 2024; 29(30) doi: 10.2807/1560-7917.ES.2024.29.30.2300651
|
| 4 |
Kathleen N. Ly, Laurie K. Barker, Greta Kilmer, Jaimie Z. Shing, Ruth B. Jiles, Eyasu Teshale. Disparities in hepatitis C among people aged 12–59 with no history of injection drug use, United States, January 2013–March 2020. Liver International 2024; 44(12): 3250 doi: 10.1111/liv.16108
|
| 5 |
Kathleen N Ly, Arialdi M Miniño, Stephen J Liu, Henry Roberts, Elizabeth M Hughes, John W Ward, Ruth B Jiles. Deaths Associated With Hepatitis C Virus Infection Among Residents in 50 States and the District of Columbia, 2016–2017. Clinical Infectious Diseases 2020; 71(5): 1149 doi: 10.1093/cid/ciz976
|
| 6 |
Lingbao Kong, Akira Fujimoto, Mariko Nakamura, Haruyo Aoyagi, Mami Matsuda, Koichi Watashi, Ryosuke Suzuki, Minetaro Arita, Satoshi Yamagoe, Naoshi Dohmae, Takehiro Suzuki, Yuriko Sakamaki, Shizuko Ichinose, Tetsuro Suzuki, Takaji Wakita, Hideki Aizaki, J.-H. J. Ou. Prolactin Regulatory Element Binding Protein Is Involved in Hepatitis C Virus Replication by Interaction with NS4B. Journal of Virology 2016; 90(6): 3093 doi: 10.1128/JVI.01540-15
|
| 7 |
Anjiya Shaikh, Karthik Goli, Tzu-Hao Lee, Nicole E. Rich, Jihane N. Benhammou, Stephanie Keeling, Donghee Kim, Aijaz Ahmed, John Goss, Abbas Rana, Amit G. Singal, Fasiha Kanwal, George Cholankeril. Reduction in Racial and Ethnic Disparity in Survival Following Liver Transplant for Hepatocellular Carcinoma in the Direct-acting Antiviral Era. Clinical Gastroenterology and Hepatology 2023; 21(9): 2288 doi: 10.1016/j.cgh.2022.11.038
|
| 8 |
Chelsea Masterman, Andrew B. Mendlowitz, Camelia Capraru, Karen Campbell, Genevieve Eastabrook, Mark H. Yudin, Tatyana Kushner, Jennifer A. Flemming, Jordan J. Feld, Yolanda Babenko-Mould, Panagiota Tryphonopoulos, Mia Biondi. An evolutionary concept analysis: stigma among women living with hepatitis C. BMC Public Health 2024; 24(1) doi: 10.1186/s12889-024-20131-6
|
| 9 |
Thein Min Swe, Derek. C. Johnson, Htay Thet Mar, Phone Thit, Tobias Homan, Cherry May Chu, Phyu Ei Mon, Thin Thin Thwe, Kyi Pyar Soe, Win Le Shwe Sin Ei, Nyan Lynn Tun, Kyaw Zay Lwin, Hayk Karakozian, Khin Sanda Aung, Aude Nguyen, Iza Ciglenecki, Natalia Tamayo, Anne Loarec. Epidemiological characteristics and real‐world treatment outcomes of hepatitis C among HIV/HCV co‐infected patients in Myanmar: A prospective cohort study. Health Science Reports 2023; 6(2) doi: 10.1002/hsr2.1119
|
| 10 |
Tomohiro Tanaka, Krista L. Lentine, Qianyi Shi, Mark Vander Weg, David A. Axelrod. Differential Impact of the UNOS Simultaneous Liver-kidney Transplant Policy Change Among Patients With Sustained Acute Kidney Injury. Transplantation 2023; doi: 10.1097/TP.0000000000004774
|
| 11 |
Kathleen N. Ly, Justin K. Niles, Ruth B. Jiles, Harvey W. Kaufman, Mark K. Weng, Priti Patel, William A. Meyer, William W. Thompson, Nicola D. Thompson. Hepatitis C Virus Testing, Infection, and Cases Reported Through Public Health Surveillance During Expanded Screening Recommendations, United States, 2013-2021. Public Health Reports® 2024; doi: 10.1177/00333549231224199
|
| 12 |
Maeve McNamara, Nathan Furukawa, Emily J. Cartwright. Advancing Hepatitis C Elimination through Opt-Out Universal Screening and Treatment in Carceral Settings, United States. Emerging Infectious Diseases 2024; 30(13) doi: 10.3201/eid3013.230859
|
| 13 |
François Girardin, Natalie Hearmon, Francesco Negro, Lucy Eddowes, Philip Bruggmann, Erika Castro. Increasing hepatitis C virus screening in people who inject drugs in Switzerland using rapid antibody saliva and dried blood spot testing: A cost‐effectiveness analysis. Journal of Viral Hepatitis 2019; 26(2): 236 doi: 10.1111/jvh.13023
|
| 14 |
Takako Inoue, Tomoyuki Ohike, Kumiko Ohne, Shigeru Sato, Takaaki Goto, Yasuhito Tanaka. Clinical Evaluation of a Newly Developed Chemiluminescent Enzyme Immunoassay for Hepatitis C Virus Core Antigen in Japan. Japanese Journal of Infectious Diseases 2019; 72(5): 285 doi: 10.7883/yoken.JJID.2018.472
|
| 15 |
Reza Taherkhani, Fatemeh Farshadpour. Lurking epidemic of hepatitis C virus infection in Iran: A call to action. World Journal of Hepatology 2017; 9(24): 1040-1042 doi: 10.4254/wjh.v9.i24.1040
|
| 16 |
Cecilia Trucchi, Andrea Orsi, Cristiano Alicino, Laura Sticchi, Giancarlo Icardi, Filippo Ansaldi. State of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and Immunization. Journal of Immunology Research 2016; 2016: 1 doi: 10.1155/2016/1412840
|
| 17 |
A. M. Buchanan-Hughes, M. Buti, K. Hanman, B. Langford, M. Wright, L. A. Eddowes. Health state utility values measured using the EuroQol 5-dimensions questionnaire in adults with chronic hepatitis C: a systematic literature review and meta-analysis. Quality of Life Research 2019; 28(2): 297 doi: 10.1007/s11136-018-1992-3
|
| 18 |
Erica Diani, Anna Lagni, Virginia Lotti, Emil Tonon, Riccardo Cecchetto, Davide Gibellini. Vector-Transmitted Flaviviruses: An Antiviral Molecules Overview. Microorganisms 2023; 11(10): 2427 doi: 10.3390/microorganisms11102427
|
| 19 |
Edward J. Gane, Christian Schwabe, Robert H. Hyland, Yin Yang, Evguenia Svarovskaia, Luisa M. Stamm, Diana M. Brainard, John G. McHutchison, Catherine A. Stedman. Efficacy of the Combination of Sofosbuvir, Velpatasvir, and the NS3/4A Protease Inhibitor GS-9857 in Treatment-Naïve or Previously Treated Patients With Hepatitis C Virus Genotype 1 or 3 Infections. Gastroenterology 2016; 151(3): 448 doi: 10.1053/j.gastro.2016.05.021
|
| 20 |
Ergenekon Karagöz, Alpaslan Tanoğlu, Asim Ülçay, Hakan Erdem, Vedat Turhan, Muammer Kara, Yusuf Yazgan. Mean platelet volume and red cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in patients with chronic hepatitis C. European Journal of Gastroenterology & Hepatology 2016; 28(7): 744 doi: 10.1097/MEG.0000000000000647
|
| 21 |
Valentina Pecoraro, Rita Banzi, Elisabetta Cariani, Johanna Chester, Erica Villa, Roberto D'Amico, Vittorio Bertele', Tommaso Trenti. New Direct-Acting Antivirals for the Treatment of Patients With Hepatitis C Virus Infection: A Systematic Review of Randomized Controlled Trials. Journal of Clinical and Experimental Hepatology 2019; 9(4): 522 doi: 10.1016/j.jceh.2018.07.004
|
| 22 |
Napas Rodprasert, Tinn Hongboontry, Chitchanok Cherdchoochart, Roongruedee Chaiteerakij. Association between Liver Stiffness and Liver-Related Events in HCV-Infected Patients after Successful Treatment with Direct-Acting Antivirals. Medicina 2023; 59(3): 602 doi: 10.3390/medicina59030602
|
| 23 |
Takako Inoue, Su Su Hmwe, Noritomo Shimada, Keizo Kato, Tatsuya Ide, Takuji Torimura, Takashi Kumada, Hidenori Toyoda, Akihito Tsubota, Koichi Takaguchi, Takaji Wakita, Yasuhito Tanaka, Ranjit Ray. Clinical Significance of Two Real-Time PCR Assays for Chronic Hepatitis C Patients Receiving Protease Inhibitor-Based Therapy. PLOS ONE 2017; 12(1): e0170667 doi: 10.1371/journal.pone.0170667
|
| 24 |
Sherif M. Shawky, Ahmed M. Awad, Walaa Allam, Mohamed H. Alkordi, Sherif F. EL-Khamisy. Gold aggregating gold: A novel nanoparticle biosensor approach for the direct quantification of hepatitis C virus RNA in clinical samples. Biosensors and Bioelectronics 2017; 92: 349 doi: 10.1016/j.bios.2016.11.001
|
| 25 |
Ana Virseda-Berdices, Oscar Brochado-Kith, Cristina Díez, Victor Hontañon, Juan Berenguer, Juan González-García, David Rojo, Amanda Fernández-Rodríguez, Luis Ibañez-Samaniego, Elba Llop-Herrera, Antonio Olveira, Leire Perez-Latorre, Coral Barbas, Marta Rava, Salvador Resino, María Angeles Jiménez-Sousa. Blood microbiome is associated with changes in portal hypertension after successful direct-acting antiviral therapy in patients with HCV-related cirrhosis. Journal of Antimicrobial Chemotherapy 2022; 77(3): 719 doi: 10.1093/jac/dkab444
|
| 26 |
Melanie L Yarbrough, Carey-Ann D Burnham. The ABCs of STIs: An Update on Sexually Transmitted Infections. Clinical Chemistry 2016; 62(6): 811 doi: 10.1373/clinchem.2015.240234
|
| 27 |
Xi Khai Wong, Chen Seng Ng, Keng Yoon Yeong. Shaping the future of antiviral Treatment: Spotlight on Nucleobase-Containing drugs and their revolutionary impact. Bioorganic Chemistry 2024; 144: 107150 doi: 10.1016/j.bioorg.2024.107150
|
| 28 |
Muhammad Nauman Zahid. Transplantation of Organs from Hepatitis C Virus-Positive Donors under Direct-Acting Antiviral Regimens. Journal of Clinical Medicine 2022; 11(3): 770 doi: 10.3390/jcm11030770
|
| 29 |
Francois Rollin, Maeve McNamara, Lana Aleuy, Jennifer Lom, Siri Chirumamilla, Alexander Molinari, Lesley Miller, Shelly-Ann Fluker. Real world experience in treatment of chronic hepatitis C in patients with compensated and decompensated cirrhosis. Future Virology 2024; 19(10-11): 393 doi: 10.1080/17460794.2024.2415213
|
| 30 |
Takako Inoue, Takaaki Goto, Etsuko Iio, Kayoko Matsunami, Kei Fujiwara, Noboru Shinkai, Kentaro Matsuura, Takeshi Matsui, Shunsuke Nojiri, Yasuhito Tanaka. Changes in serum lipid profiles caused by three regimens of interferon‐free direct‐acting antivirals for patients infected with hepatitis C virus. Hepatology Research 2018; 48(3) doi: 10.1111/hepr.12970
|